Scottsdale Interventional Forum 2018
Avatar

Navigating the Landscape of Anti-Thrombotic and DAPT Strategies in PCI

By Scottsdale Interventional Forum 2018 FEATURING James Hermiller
May 2018
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
Didactic Presentations

Heart of Battle: Sentara Shock Symposium

Sat, Oct 19, 2019
57:14
Northwestern Medicine Cardiovascular Care

Stress Testing in the Real World

Feat. M. Eimer
24:31
American Society of Nuclear Cardiology

58 Year-Old Man with Exertional Chest Discomfort

Feat. R. Doukky
20:18
ASPC 2019 Congress on CVD Prevention

The 2018 ACC/AHA Prevention Guidelines - Advancing a Comprehensive Appro...

Feat. R. Blumenthal
07:45
Cardiometabolic Health Congress (CMHC)

Interactive Patient Case Discussion - Calculating Cardiovascular Disease...

Feat. C. Ballantyne
16:55
Scottsdale Interventional Forum 2015

PCI Pharmacology in 2015: Choosing the Right Antiplatelet & Anticoagulan...

Feat. S. Bailey
05:58
Complex Coronary Valvular and Vascular Cases Conference

Newer P2 Y12 Inhibitors in ACS: Losing Ground Due to Bleeding

Feat. S. Rao
12:53
Scottsdale Interventional Forum 2018

What is the Optimal DAPT Duration?

Feat. R. Yeh
17:19
Scottsdale Interventional Forum 2014

Essentials of ACS/PCI Pharmacology: An Overview and Approach

Feat. R. Harrington
22:52
Northwestern Medicine Cardiovascular Care

ST-Elevation MI: The State of the Art

Feat. J. Flaherty
21:51
Complex Coronary Valvular and Vascular Cases Conference

Optimal Duration of DAPT: Update on DAPT Guidelines

Feat. R. Mehran
23:46
ASPC 2018 Congress on CVD Prevention

Differentiating Antiplatelet Agents

Feat. P. Toth
22:08
Scottsdale Interventional Forum 2013

Antithrombotic Pharmacology in ACS PCI: What’s Practical, What’s in the ...

Feat. R. Harrington
20:24
Complex Interventional Cardiovascular Therapy (CICT) 2015

DAPT after coronary stenting should be limited to 6 months

09:11
Scottsdale Interventional Forum 2018

PCI in the Setting of AFib: The Pharmacologic Strategy

Feat. M. Kutcher
53:27
Rush Heart

Dual Antiplatelet Therapy After PCI or ACS

Feat. G. Schaer
19:07
Northwestern Medicine: 6th Annual Cardiovascular Update

NSTEMI - State of the Art

Feat. R. Sweis
18:60
San Diego Cardiovascular Interventions (SDCI) 2018

Intravenous ADP Antagonist for PCI

Feat. M. Patel
13:11
ARCH Advanced Revascularization Symposium

Update on Dual Antiplatelet Therapy (DAPT)

Feat. G. Dangas
12:03
Complex Cardiovascular Catheter Therapeutics (C3)

What are the Major Pharmacodynamic and Safety Differences Between Antipl...

Feat. S. Nathan
40:17
ARCH Advanced Revascularization Symposium

Top Trials in Interventional Cardiology in 2015-2016

Feat. J. Popma